Evidence
Ginger for mild nausea
What Remedary says
Self-care context for mild, short-lived nausea in otherwise healthy adults.
Not adequately studied
What this covers
There is not enough relevant research to reach a conclusion. Not studied does not mean ineffective.
What the research suggests
Evidence is limited. Ginger has been studied for nausea, but the evidence currently reviewed here isn't strong enough to say that it reliably helps with mild nausea in general.
How it is used
Ginger can be prepared as an infusion or incorporated into everyday foods. The recipes below are practical ways to use ginger and are not therapeutic doses.
Before using this
Household preparations
A practical way to use this ingredient may not match the form or amount in the research.
A simple hot-water preparation that lets you adjust fresh ginger strength to taste.
Crisp-edged ginger cookies using both fresh and ground ginger for a pronounced ginger flavor.
A fast ginger-forward vegetable dinner with tofu as the default and chicken as an optional substitution.
Fresh ginger and lemon in a bright, easy hot-water preparation with optional honey.
A make-ahead fresh-ginger dressing for salads, grain bowls, noodles, and cooked vegetables.
A make-ahead refrigerator concentrate for stirring into warm water.
A plant-based ginger-and-thyme soup with chickpeas and vegetables.
No-bake date-and-oat snack bites with warm spices and a noticeable ginger note.
Warm baked pears flavored with ginger and a small amount of honey.
A make-ahead breakfast with fresh ginger and a touch of honey.
Sources
3 sources. The number of sources does not measure how strong the evidence is.
National Center for Complementary and Integrative Health · Government health resource · Background source
What was studiedPorted from staged P0 research as background. An Editor must review the source and choose its final role before relying on it publicly.
National Center for Complementary and Integrative Health · Government health resource · Background source
What was studiedPorted from staged P0 research as background. An Editor must review the source and choose its final role before relying on it publicly.
European Medicines Agency · 2024 · Regulatory monograph · Background source
What was studiedDeliberately retained as background from the legacy preparation-level evidence set; not treated as direct ingredient-level efficacy support.